» Articles » PMID: 23637551

RANTES and Fibroblast Growth Factor 2 in Jawbone Cavitations: Triggers for Systemic Disease?

Overview
Journal Int J Gen Med
Publisher Dove Medical Press
Specialty General Medicine
Date 2013 May 3
PMID 23637551
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Jawbone cavitations (JC) are hollow dead spaces in jawbones with dying or dead bone marrow. These areas are defined as fatty degenerative osteonecrosis of the jawbone or neuralgia-inducing cavitational osteonecrosis and may produce facial pain. These afflictions have been linked to the immune system and chronic illnesses. Surgical debridement of JC is reported to lead to an improvement in immunological complaints, such as rheumatic, allergic, and other inflammatory diseases (ID). Little is known about the underlying cause/effect relationship.

Objectives: JC bone samples were analyzed to assess the expression and quantification of immune modulators that can play a role in the pathogenesis of IDs. The study supports a potential mechanism where JC is a mediating link in IDs.

Materials And Methods: Samples of fatty softened bone taken from JCs were extracted from 31 patients. The specimens were analyzed by bead-based multiplex technology and tested for seven immune messengers.

Results: Regulated upon activation, normal T-cell expressed, and secreted (RANTES) and fibroblast growth factor (FGF)-2 were found at high levels in the JCs tested. Other cytokines could not be detected at excessive levels.

Discussion: The study confirms that JC is able to produce inflammatory messengers, primarily RANTES, and, secondarily, FGF-2. Both are implicated in many serious illnesses. The excessive levels of RANTES/FGF-2 in JC patients with amyotrophic lateral sclerosis, multiple sclerosis, rheumatoid arthritis, and breast cancer are compared to levels published in medical journals. Levels detected in JCs are higher than in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis and multiple sclerosis patients and four-fold higher than in breast cancer tissue.

Conclusion: This study suggests that JC might serve as a fundamental cause of IDs, through RANTES/FGF-2 production. Thus, JC and implicated immune messengers represent an integrative aspect of IDs and serve as a possible cause. Removing JCs may be a key to reversing IDs. There is a need to raise awareness about JC throughout medicine and dentistry.

Citing Articles

Fatty Degenerative Osteonecrosis of the Jaw: Bridging Molecular Insights and Clinical Practice-A Scoping Review.

Dominiak M, Niemczyk W, Pitulaj A, Swienc W, Matys J Int J Mol Sci. 2025; 26(5).

PMID: 40076479 PMC: 11899097. DOI: 10.3390/ijms26051853.


Dental Ultrasonography for Visualizing Osteoimmune Conditions and Assessing Jaw Bone Density: A Narrative Review.

Huber R, Choukroun E, Fahrenholz H, Notter F Med Devices (Auckl). 2025; 18():1-13.

PMID: 39801671 PMC: 11724658. DOI: 10.2147/MDER.S491331.


Platelet-Rich Fibrin (PRF) Analyzed for Cytokine Profiles - A Misguided Hope for Osteogenesis in Jawbone Defects? Research and Clinical Observational Study.

Lechner J, vonBaehr V, Doebis C, Notter F, Schick F Clin Cosmet Investig Dent. 2024; 16:467-479.

PMID: 39583889 PMC: 11585297. DOI: 10.2147/CCIDE.S488206.


Involvement of Root Canal Treatment in Pro-Inflammatory Processes - A Real-World Study.

Diederich J, Muller K Pragmat Obs Res. 2024; 15:165-172.

PMID: 39346572 PMC: 11438457. DOI: 10.2147/POR.S479124.


Osteoimmune Interaction and TH-1/TH-2 Ratio in Jawbone Marrow Defects: An Underestimated Association - Original Research.

Lechner J, von Baehr V, Notter F, Schick F Biologics. 2024; 18:147-161.

PMID: 38859969 PMC: 11164205. DOI: 10.2147/BTT.S448587.


References
1.
Fischer M, Juremalm M, Olsson N, Backlin C, Sundstrom C, Nilsson K . Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue. Int J Cancer. 2003; 107(2):197-201. DOI: 10.1002/ijc.11370. View

2.
Sarchielli P, Di Filippo M, Ercolani M, Chiasserini D, Mattioni A, Bonucci M . Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. Neurosci Lett. 2008; 435(3):223-8. DOI: 10.1016/j.neulet.2008.02.040. View

3.
Arend W . The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002; 13(4-5):323-40. DOI: 10.1016/s1359-6101(02)00020-5. View

4.
Azenshtein E, Luboshits G, Shina S, Neumark E, Shahbazian D, Weil M . The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res. 2002; 62(4):1093-102. View

5.
Bouquot J, Roberts A, PERSON P, Christian J . Neuralgia-inducing cavitational osteonecrosis (NICO). Osteomyelitis in 224 jawbone samples from patients with facial neuralgia. Oral Surg Oral Med Oral Pathol. 1992; 73(3):307-19; discussion 319-20. DOI: 10.1016/0030-4220(92)90127-c. View